Ambulatory Infusion Center Market, By Therapy Type (Blood Product Infusion, Iron Therapy, Steroid Infusion, Immunoglobulin Therapy, Therapeutic Phlebotomy, Plasmapheresis, Clotting Factor Replacement Therapy, and Others), By Application (Diabetic, Cancer, Bone Diseases, Neurodegenerative Diseases, and Others), By End User (Hospitals, Specialty Clinics, Homecare Settings, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Jul 2024

Code : CMI4318

Pages :175

Formats :

Excel and PDF

Industry : Medical Devices

Market Challenges: High costs associated with the devices and therapies

High costs associated with devices and therapies have been a major obstacle in the widespread adoption of ambulatory infusion centers globally. The expenses incurred on advanced medical equipment, professional healthcare services, and pharmaceutical drugs administered through these centers are significantly high. This makes treatment through ambulatory infusion centers unaffordable for a large section of population worldwide especially in underdeveloped and developing nations. The equipment required for safe and effective infusion of drugs outside hospital setup is expensive. Devices like large volume infusion pumps, vital sign monitors and consumables like sterile collection bags, medication bags, tubing sets, etc. attract high prices. Similarly, costs of biologics, antibodies, and specialty pharmaceuticals used through ambulatory infusion are also on the rise.

Market Opportunities: Development of specialty infusion centers

The development of specialty infusion centers could usher in a tremendous opportunity for the global ambulatory infusion center market. Specialty infusion centers are standalone, free-standing facilities dedicated to providing infusion therapies for specific conditions or patient populations. As the demand for non-emergency outpatient infusion therapies rises, specialty centers will become increasingly crucial for efficient and effective service delivery. Various trends underscore the promising future of specialty infusion centers. Chronic diseases requiring long-term IV drug therapy are on the uptick globally. For example, the number of people diagnosed with diseases like cancer, multiple sclerosis, and rheumatoid arthritis is projected to increase over the next few years according to the World Health Organization. Moreover, biologics and specialty pharmaceuticals administered through intravenous methods are at the forefront of innovation in medicine. As novel and high-cost infusion drugs enter the market at an exponential rate, specialty centers can ensure optimum clinical management and monitoring for patients on these therapies.